Health Condition 1: D578- Other sickle-cell disorders
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients were treated with T-AYU-HM Premium for sickle cell anemia at Dhanvantari Clinic between 1st January 2018 to 31st December 2020. 2.Patients with a diagnosis of Sickle Cell Anemia (SCT/SCD) 3.Patients = 5 years of age 4. Patient’s = 3 months of follow-up data available from the first treatment at the center. 5. Patient’s visited OPD of clinic regularly on scheduled appointment date 6. Patients who were hospitalized for crisis condition.
Exclusion criteria
Exclusion criteria: 1.Patients who were taking other medicines for anemia 2. Pregnant and lactating women. 3. Patient’s laboratory parameters data are not available. 4. Patients follow-up is irregular
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Effect of Treatment on Complete blood counts 2. Effect of Treatment on patients Symptoms Timepoint: At Baseline day 0, 30th, 90th and 120 days of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Effect of treatment on Number of times patient was hospitalized during the study period 2.Effect of treatment on Number of pain crisis episodes during treatment period 3.Effect of treatment on No. of times blood transfusions required during observation period Timepoint: At Baseline day 0, 30th , 90th, 120th day of treatment | — |
Countries
India
Contacts
Dhanvantari Clinic, Ayurveda health care and research